Algorhythm Holdings (RIME) Ratios

257 Followers

Algorhythm Holdings Ratios

RIME's free cash flow for Q4 2025 was $-0.45. For the 2025 fiscal year, RIME's free cash flow was decreased by $ and operating cash flow was $-2.96. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 25	Jun 23	Jun 22
Liquidity Ratios
Current Ratio	―	0.55	0.59	1.43	2.48
Quick Ratio	―	0.55	0.51	1.01	1.00
Cash Ratio	―	0.11	0.27	0.41	0.47
Solvency Ratio	―	-1.08	-0.79	-0.40	-0.58
Operating Cash Flow Ratio	―	-0.68	-0.30	0.03	-0.05
Short-Term Operating Cash Flow Coverage	―	-0.86	-32.29	0.00	-4.08
Net Current Asset Value	$ ―	$ -6.65M	$ -12.06M	$ 3.07M	$ 8.88M
Leverage Ratios
Debt-to-Assets Ratio	―	0.90	0.04	0.14	0.04
Debt-to-Equity Ratio	―	-97.45	-0.07	0.53	0.07
Debt-to-Capital Ratio	―	1.01	-0.07	0.35	0.07
Long-Term Debt-to-Capital Ratio	―	0.00	-0.04	0.00	<0.01
Financial Leverage Ratio	―	-108.75	-1.93	3.66	1.61
Debt Service Coverage Ratio	―	-1.17	-10.23	-19.59	-5.74
Interest Coverage Ratio	―	-10.64	-7.38	-20.55	-7.72
Debt to Market Cap	―	4.56	<0.01	0.00	<0.01
Interest Debt Per Share	―	4.91	0.28	0.91	0.43
Net Debt to EBITDA	―	-0.69	0.31	0.35	0.99
Profitability Margins
Gross Profit Margin	―	-29.95%	20.35%	21.20%	23.43%
EBIT Margin	―	-328.31%	-95.68%	-21.04%	-7.96%
EBITDA Margin	―	-322.64%	-93.73%	-20.06%	-5.55%
Operating Profit Margin	―	-181.01%	-59.27%	-21.04%	-9.41%
Pretax Profit Margin	―	-345.32%	-103.72%	-21.91%	-9.18%
Net Profit Margin	―	-365.52%	-98.99%	-21.91%	-11.80%
Continuous Operations Profit Margin	―	-346.39%	-103.72%	-21.91%	-11.80%
Net Income Per EBT	―	105.85%	95.44%	100.00%	128.55%
EBT Per EBIT	―	190.78%	174.99%	104.15%	97.57%
Return on Assets (ROA)	―	-126.14%	-127.07%	-30.78%	-27.86%
Return on Equity (ROE)	―	13717.95%	245.20%	-112.57%	-44.89%
Return on Capital Employed (ROCE)	―	463.17%	137.38%	-71.19%	-35.14%
Return on Invested Capital (ROIC)	―	-82.06%	141.07%	-70.67%	-33.28%
Return on Tangible Assets	―	-199.70%	-135.44%	-30.78%	-27.86%
Earnings Yield	―	-641.99%	-14.21%	-0.87%	-0.53%
Efficiency Ratios
Receivables Turnover	―	4.14	4.44	5.14	16.98
Payables Turnover	―	4.04	4.91	4.03	17.01
Inventory Turnover	―	0.00	8.56	4.46	3.31
Fixed Asset Turnover	―	199.59	61.99	8.99	32.91
Asset Turnover	―	0.35	1.28	1.40	2.36
Working Capital Turnover Ratio	―	-0.48	-10.04	4.84	4.16
Cash Conversion Cycle	―	-2.19	50.49	62.18	110.24
Days of Sales Outstanding	―	88.20	82.12	71.04	21.49
Days of Inventory Outstanding	―	0.00	42.64	81.75	110.20
Days of Payables Outstanding	―	90.39	74.28	90.62	21.46
Operating Cycle	―	88.20	124.76	152.79	131.70
Cash Flow Ratios
Operating Cash Flow Per Share	―	-3.98	-0.94	0.11	-0.12
Free Cash Flow Per Share	―	-3.98	-0.95	0.09	-0.20
CapEx Per Share	―	<0.01	<0.01	0.02	0.09
Free Cash Flow to Operating Cash Flow	―	1.00	1.01	0.83	1.74
Dividend Paid and CapEx Coverage Ratio	―	-703.43	-122.23	6.04	-1.35
Capital Expenditure Coverage Ratio	―	-703.43	-122.23	6.04	-1.35
Operating Cash Flow Coverage Ratio	―	-0.86	-13.16	0.14	-0.45
Operating Cash Flow to Sales Ratio	―	-2.24	-0.36	0.01	>-0.01
Free Cash Flow Yield	―	-394.47%	-5.27%	0.05%	-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.16	-7.04	-114.77	-189.17
Price-to-Sales (P/S) Ratio	―	0.57	6.97	25.15	22.33
Price-to-Book (P/B) Ratio	―	-21.37	-17.26	129.20	84.93
Price-to-Free Cash Flow (P/FCF) Ratio	―	-0.25	-18.98	2.14K	-1.53K
Price-to-Operating Cash Flow Ratio	―	-0.25	-19.14	1.79K	-2.66K
Price-to-Earnings Growth (PEG) Ratio	―	>-0.01	-0.16	-17.22	0.15
Price-to-Fair Value	―	-21.37	-17.26	129.20	84.93
Enterprise Value Multiple	―	-0.87	-7.12	-125.05	-400.92
Enterprise Value	―	12.27M	156.82M	976.39M	875.20M
EV to EBITDA	―	-0.87	-7.12	-125.05	-400.92
EV to Sales	―	2.79	6.67	25.08	22.27
EV to Free Cash Flow	―	-1.24	-18.18	2.13K	-1.52K
EV to Operating Cash Flow	―	-1.25	-18.33	1.78K	-2.65K
Tangible Book Value Per Share	―	-2.64	-1.28	1.56	3.67
Shareholders’ Equity Per Share	―	-0.05	-1.04	1.56	3.67
Tax and Other Ratios
Effective Tax Rate	―	>-0.01	0.00	0.00	-0.29
Revenue Per Share	―	1.77	2.58	8.03	13.98
Net Income Per Share	―	-6.48	-2.56	-1.76	-1.65
Tax Burden	―	1.06	0.95	1.00	1.29
Interest Burden	―	1.05	1.08	1.04	1.15
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	1.51	0.64	0.27	0.24
Stock-Based Compensation to Revenue	―	0.00	0.03	<0.01	<0.01
Income Quality	―	0.68	0.35	-0.06	0.07

Currency in USD